Neurogene, Inc. (NGNE)
24.30
+0.37
(+1.55%)
USD |
NASDAQ |
Nov 16, 10:26
Neurogene Price : 24.30 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 23.96 | 24.50 | 23.29 | 23.93 | 193619.0 |
| Nov 12, 2026 | 24.77 | 24.99 | 22.70 | 23.90 | 237853.0 |
| Nov 11, 2026 | 25.53 | 26.94 | 24.83 | 25.10 | 199764.0 |
| Nov 10, 2026 | 25.22 | 26.34 | 24.22 | 25.28 | 344521.0 |
| Nov 09, 2026 | 26.26 | 26.75 | 24.45 | 26.00 | 442082.0 |
| Nov 06, 2026 | 26.33 | 27.26 | 24.68 | 25.31 | 324882.0 |
| Nov 05, 2026 | 27.61 | 28.50 | 25.57 | 25.65 | 380859.0 |
| Nov 04, 2026 | 27.79 | 28.10 | 26.15 | 27.58 | 208919.0 |
| Nov 03, 2026 | 27.11 | 28.59 | 26.43 | 26.67 | 186625.0 |
| Nov 02, 2026 | 27.85 | 29.22 | 26.46 | 26.61 | 173621.0 |
| Oct 30, 2026 | 28.53 | 29.38 | 26.76 | 27.55 | 249047.0 |
| Oct 29, 2026 | 30.50 | 32.09 | 28.50 | 28.82 | 309996.0 |
| Oct 28, 2026 | 26.99 | 31.14 | 25.81 | 30.42 | 646310.0 |
| Oct 27, 2026 | 23.71 | 27.22 | 23.26 | 26.99 | 484953.0 |
| Oct 26, 2026 | 23.75 | 24.43 | 23.32 | 23.54 | 123203.0 |
| Oct 23, 2026 | 24.11 | 24.11 | 23.08 | 23.55 | 124512.0 |
| Oct 22, 2026 | 25.74 | 26.38 | 24.09 | 24.28 | 212381.0 |
| Oct 21, 2026 | 25.52 | 26.94 | 25.10 | 26.08 | 588808.0 |
| Oct 20, 2026 | 24.20 | 25.84 | 23.80 | 25.40 | 205898.0 |
| Oct 19, 2026 | 23.26 | 24.39 | 22.78 | 24.17 | 240177.0 |
| Oct 16, 2026 | 24.00 | 24.27 | 23.00 | 23.25 | 571531.0 |
| Oct 15, 2026 | 22.35 | 24.41 | 22.35 | 23.95 | 587986.0 |
| Oct 14, 2026 | 21.05 | 22.50 | 21.05 | 22.18 | 522546.0 |
| Oct 13, 2026 | 24.32 | 25.17 | 21.40 | 21.56 | 442253.0 |
| Oct 12, 2026 | 26.13 | 27.15 | 24.19 | 24.44 | 388006.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.08 |
| Alnylam Pharmaceuticals, Inc. | 161.29 |
| Anika Therapeutics, Inc. | 13.07 |
| Savara, Inc. | 4.55 |
| Arrowhead Pharmaceuticals, Inc. | 45.86 |
Price Related Metrics
| PEG Ratio | -0.1707 |
| Price to Book Value | 1.417 |
| Earnings Yield | -22.88% |
| Market Cap | 502.85M |
| PEGY Ratio | -0.1707 |